India's MedPlus Health Services reported a two-fold surge in fourth-quarter profit on Thursda...
Alembic Pharmaceuticals is currently trading at Rs. 574.85, up by 3.10 points or 0.54% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 486.70, up by 2.25 points or 0.46% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 490.50, up by 3.20 points or 0.66% from its p...
US inflection unlikely soon; ADD retained Result Synopsis Alembic Pharma managed to report ...
Alembic Pharma gets USFDA nod to market generic antidepressant drug: Alembic Pharmaceuticals o...
Alembic Pharmaceuticals is currently trading at Rs. 519.05, up by 6.75 points or 1.32% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 516.90, up by 15.35 points or 3.06% from its ...
Alembic Pharmaceuticals is currently trading at Rs. 587.10, up by 5.50 points or 0.95% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 589.85, up by 1.20 points or 0.20% from its p...
Strong execution drives earnings beat Enhanced effort required to improve return ratios; maint...
Alembic Pharmaceuticals is currently trading at Rs. 597.95, up by 2.95 points or 0.50% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 630.75, up by 5.40 points or 0.86% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 647.70, up by 8.40 points or 1.31% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 661.55, up by 49.35 points or 8.06% from its ...
Alembic Pharmaceuticals is currently trading at Rs. 602.05, up by 23.60 points or 4.08% from its ...
Alembic Pharmaceuticals is currently trading at Rs. 553.30, up by 3.35 points or 0.61% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 549.20, up by 1.05 points or 0.19% from its p...
Numbers dwindle; US traction key for margins, return ratios About the stock: Alembic Pharma op...
Alembic Pharmaceuticals is currently trading at Rs. 656.00, up by 5.60 points or 0.86% from its p...
Margin pressure from US leads a D/G to ADD Result Synopsis Alembic Pharma reported an extre...
Alembic Pharmaceuticals is currently trading at Rs. 701.80, up by 0.65 points or 0.09% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 735.70, up by 3.60 points or 0.49% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 767.75, up by 7.35 points or 0.97% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 730.00, up by 4.90 points or 0.68% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 726.60, up by 6.35 points or 0.88% from its p...
Await US capex monetization Result Synopsis Alembic clocked 11% growth in 4Q, on the back o...
The company reported standalone net profit of Rs 251.37 crore for the quarter ended March 31, 202...
Alembic Pharmaceuticals is currently trading at Rs. 784.40, up by 2.65 points or 0.34% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 764.00, up by 15.20 points or 2.03% from its ...
Key News Hero MotoCorp made over Rs 1k-cr bogus expenses, I-T search reveals: Report The In...
Alembic Pharmaceuticals is currently trading at Rs. 729.90, up by 0.85 points or 0.12% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 713.55, up by 2.80 points or 0.39% from its p...
Alembic Pharmaceuticals is currently trading at Rs. 770.75, up by 8.60 points or 1.13% from its p...
Below is quote on Alembic Pharmaceuticals receives USFDA Tentative Approval for Dronedarone,...
Alembic Pharmaceuticals is currently trading at Rs. 816.90, up by 10.15 points or 1.26% from its ...
Alembic Pharmaceuticals is currently trading at Rs. 823.50, up by 7.30 points or 0.89% from its p...
Key News India's largest bank SBI to invest $20 mn in fintech firm Pine Labs Pine Labs...
Alembic Pharmaceuticals is currently trading at Rs. 812.00, up by 2.40 points or 0.30% from its p...
Weakness in US outweighs strong performance in DF Injectables business traction hinges on succ...
India shines; US struggles Alembic Pharma (Alembic) reported Q2FY22 performance was broadly in...
US challenges offset domestic performance… About the stock: Alembic Pharma operates in ...
Alembic Pharmaceuticals is currently trading at Rs. 827.55, up by 8.10 points or 0.99% from its p...
Below is quote on Alembic Pharmaceuticals receive EIR from USFDA by Mr. Yash ...
Religare Super Idea To Read Complete Report & Disclaimer Click Here ...
Key MeetingTakeaways US business: * Pivoting from supply-focused to volume-focused strategy...
US challenges offset domestic recovery… About the stock: Alembic Pharma operates in...
INVESTMENT THESIS Alembic Pharmaceuticals Ltd (‘ALPM’) reported a weaker than expe...